Sabra Healthcare REIT (NASDAQ:SBRA) Stock Gets Price Target Boost from Mizuho

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) had its price objective upped by equities researchers at Mizuho from $21.00 to $22.00 in a research report issued on Monday, Benzinga reports. The firm currently has a “neutral” rating on the real estate investment trust’s stock. Mizuho‘s price target suggests a potential upside of 7.33% from the stock’s current price.

A number of other brokerages have also recently weighed in on SBRA. Deutsche Bank reissued a “buy” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Citigroup restated a “market outperform” rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Wells Fargo & Company raised their price objective on shares of Sabra Healthcare REIT from $21.00 to $23.00 and gave the stock an “overweight” rating in a report on Monday. Truist Financial increased their target price on Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a report on Wednesday, July 22nd. Finally, Robert W. Baird lifted their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research note on Monday, August 31st. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Sabra Healthcare REIT currently has a consensus rating of “Moderate Buy” and an average target price of $21.92.

Get Our Latest Stock Analysis on Sabra Healthcare REIT

Sabra Healthcare REIT Trading Up 0.3%

SBRA traded up $0.06 during mid-day trading on Monday, reaching $20.50. The stock had a trading volume of 390,340 shares, compared to its average volume of 2,677,219. The firm’s fifty day simple moving average is $19.88 and its two-hundred day simple moving average is $20.04. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.21 and a current ratio of 1.21. The stock has a market capitalization of $5.37 billion, a P/E ratio of 73.20, a P/E/G ratio of 1.78 and a beta of 0.68. Sabra Healthcare REIT has a 52 week low of $17.53 and a 52 week high of $22.77.

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last released its earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.05). Sabra Healthcare REIT had a net margin of 7.78% and a return on equity of 2.55%. The business had revenue of $249.57 million for the quarter, compared to analyst estimates of $236.64 million. During the same quarter in the previous year, the company posted $0.38 earnings per share. The business’s revenue for the quarter was up 31.4% on a year-over-year basis. On average, equities analysts predict that Sabra Healthcare REIT will post 1.52 EPS for the current year.

Insider Buying and Selling

In other Sabra Healthcare REIT news, CEO Richard K. Matros sold 200,000 shares of the company’s stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total value of $4,166,000.00. Following the transaction, the chief executive officer directly owned 1,657,686 shares of the company’s stock, valued at $34,529,599.38. This represents a 10.77% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Foster sold 10,000 shares of Sabra Healthcare REIT stock in a transaction dated Wednesday, November 11th. The stock was sold at an average price of $20.98, for a total transaction of $209,800.00. Following the completion of the sale, the director owned 72,834 shares of the company’s stock, valued at $1,528,057.32. This trade represents a 12.07% decrease in their position. The SEC filing for this sale provides additional information. 1.09% of the stock is currently owned by insiders.

Institutional Trading of Sabra Healthcare REIT

A number of institutional investors have recently modified their holdings of the stock. Lasalle Investment Management Securities LLC raised its stake in Sabra Healthcare REIT by 8.2% in the first quarter. Lasalle Investment Management Securities LLC now owns 3,824,622 shares of the real estate investment trust’s stock valued at $73,547,000 after purchasing an additional 290,405 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Sabra Healthcare REIT by 7.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,725,337 shares of the real estate investment trust’s stock valued at $71,640,000 after buying an additional 269,793 shares in the last quarter. Russell Investments Group Ltd. boosted its holdings in shares of Sabra Healthcare REIT by 70.2% in the 3rd quarter. Russell Investments Group Ltd. now owns 1,856,730 shares of the real estate investment trust’s stock valued at $36,615,000 after purchasing an additional 765,527 shares in the last quarter. Rush Island Management LP bought a new position in Sabra Healthcare REIT in the first quarter valued at about $30,735,000. Finally, Sound Income Strategies LLC boosted its stake in shares of Sabra Healthcare REIT by 8.3% in the 3rd quarter. Sound Income Strategies LLC now owns 1,051,751 shares of the real estate investment trust’s stock valued at $19,815,000 after purchasing an additional 80,453 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors.

About Sabra Healthcare REIT

(Get Free Report)

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in properties used to provide healthcare and senior living services. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Sabra generally leases its properties to healthcare and senior living operators, providing real estate that supports their services. The company’s properties are located in the United States and Canada.

Further Reading

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.